Clinical trial
The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma
NCT00270101 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00270101 |
|---|---|
| Title | The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma |
| Official title | A Placebo-Controlled Study on the Effect of r-huEPO in Patients With Multiple Myeloma Followed by an Open-Label Extension |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Multiple Myeloma |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 156 |
| Start date | Jan 1, 1995 |
| Completion | Sep 1, 1996 |
| First posted | Dec 26, 2005 |
| Last update posted | May 18, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: